A Little-Known Law Gave Birth to Google -- and Countless Other Inventions


By Katharine Ku

When Google founders Larry Page and Sergey Brin spoke to my colleagues at Stanford's technology licensing office in the late 1990s, other search engines already existed.

But Page and Brin, who were graduate students at the time, believed the page-rank algorithm they had developed at Stanford was superior, even though no other entrepreneurs saw its potential. So they decided to launch a start-up. The Stanford licensing office saw merit in their idea and licensed the algorithm -- which was owned by the University -- back to the entrepreneurs. The rest is history.

It's unlikely Google would have become the world's most popular search engine without the sorts of patent protections provided by the Bayh-Dole Act, a little-known law passed in 1980. In fact, over the past 40 years, Bayh-Dole has given rise to some of our nation's most revolutionary innovations.

Universities are the birthplace of this innovation. But prior to Bayh-Dole, just a small fraction of government-funded university research initiatives ever saw the light of day. That's because the federal government retained patents that resulted from this research -- and did a poor job of licensing the patents to private firms that could turn academic discoveries into real-world products. In fact, fewer than 5 percent of all federally-funded research patents were licensed commercially.

That was bad for everyday Americans, who weren't seeing many tangible products result from the research programs funded by their tax dollars. In December 1980, the Bayh-Dole Act broke this logjam by empowering many universities, to maintain ownership of their patented inventions and commercially license them.

That enabled institutions to create a system for academics to license their discoveries. And it enabled businesses to raise the capital for follow-on research that turned discoveries into real-life products.

Bayh-Dole has yielded significant benefits for the broader U.S. economy. From 1996 to 2017, academic technology transfers generated up to $1.7 trillion in U.S. gross industrial output, according to AUTM, a non-profit that supports academic research. The law has supported nearly 6 million jobs and helped launch more than 13,000 start-ups. And it has spurred the development of over 200 new medicines.

Critics of Bayh-Dole claim that federal funding drives much of America's innovation, and that private companies reap the rewards while taking minimal risks. But that's not true. Tech transfer is still enormously risky. Even with Bayh-Dole, it's still quite difficult to commercialize many academic innovations.

As the law approaches its 40th anniversary, it's time for consumers and policymakers alike to recognize Bayh-Dole as the driving force behind so many of our most ingenious inventions. We need to protect Bayh-Dole now more than ever to foster even greater innovations in the future

Katharine Ku, the chief licensing advisor in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, served as the executive director of Stanford University's Office of Technology Licensing for 27 years. This piece originally ran at The Mercury News.

More Resources


01/10/2025
Carter Funeral Brings Rare, Needed Vision of Peace


more info


01/10/2025
Three More Biden Deceptions
The president can believe what he wants to believe, and at this point, there appears to be no convincing him otherwise.

more info


01/10/2025
A Nation Suffers Whiplash Between Biden and Trump
On any other day this might seem strange

more info


01/10/2025
Biden Admin Told Us To Censor True Info


more info


01/10/2025
Facebook Admits Error--'Fact Checkers' Still Complicit
Mark Zuckerberg seems to want to reverse Facebook's censorship efforts, but those publications that participated in the program are complicit.

more info


01/10/2025
In Defense of DEI
DEI refers to three simple but important words: diversity, equity and inclusion. These three values are indispensable

more info


01/10/2025
Woke Religion Burned People's Homes to the Ground
The wildfire devastation of Los Angeles occurred largely as a result of people in power adhering blindly and madly to a very bad religion.

more info


01/10/2025
LA's Poor Communication Should Have Residents Fuming


more info


01/10/2025
Republican Party's New Ground Game


more info


01/10/2025
Opening the DNC's Black Box
Why we're publishing a previously undisclosed list of all 448 members of the Democratic National Committee

more info


01/10/2025
The Most Under-Reported Story About Biden
What was the most under-reported news story during the Biden presidency? In the last week or so, there has been a sudden burst of recognition of the extent to which Democrats and the media worked together to cover up Biden's progressing cognitive decline. One media figure after another has com

more info


01/10/2025
Biden Is No Carter
In terms of character the 46th president doesn't come close to matching the 39th.

more info


01/10/2025
Biden Says He Could've Beaten Trump. That's Delusional
Not only is Biden overestimating his political skills, he's also ungraciously insulting his vice president.

more info


01/10/2025
Dresden in Los Angeles and Our Confederacy of Dunces
LA is burning. And the derelict people responsible are worried that they are found out as charlatans and empty suits.

more info


01/10/2025
The L.A. Apocalypse Was Entirely Predictable
Today on TAP: The hills above my hometown regularly catch fire, and developers regularly build there nonetheless.

more info



Custom Search

More Politics Articles:

Related Articles

Americans Can't Afford Insurance — and Obamacare is to Blame


The number of uninsured Americans rose in 2018 for the first time since the Affordable Care Act passed in 2010, according to the Census Bureau.

ICER Discriminates Against People with Rare Diseases


FDA officials approved a record number of rare disease treatments last year. One groundbreaking medicine treats an inherited bone condition that causes intense pain and immobility. Another treats Fabry disease, a genetic condition that can lead to kidney failure or stroke.

Minor Legislation with Massive Implications


U.S. Senator Ron Johnson (R-WI) is promoting the "Prevent Government Shutdown Act of 2019." The goal of the act is to prevent disruptive government shutdowns.

When Humans Don't Procreate


The "hook" of the story intrigued me: "This hasn't happened in all of modern history..." An email from "The Crux" last month blared, "Global population growth to virtually stop by 2100."

Beware of Bills in Sheep's Clothing


There is a bipartisan tradition of naming bills such that no reasonable person would oppose them. For instance, changes to our tax system came with the passage of the Tax Cuts and Jobs Act. Who's against jobs? And how could anyone have voted against the Patient Protection and Affordable Care Act (i.e., "Obamacare")?

Offshore Bans Hurt Working Class Americans


Congressional Democrats just betrayed America's working class.

If You Like Your Health Plan, You Can't Keep It Under a Public Option


Nearly two in three Americans support the creation of a government-sponsored health plan to compete against plans offered by private insurers, according to the most recent survey data from the Kaiser Family Foundation.

Don't Legalize Discrimination Against People With Disabilities


Imagine if the federal government treated disabled Americans as second-class citizens. It's an appalling thought. But it could happen soon -- if some special interest groups get their way.

It's Time to Turn the Prescription Drug Debate on its Head


Politicians typically blame drug companies for soaring pharmacy prices. But insurers, pharmacies, and other middlemen are the real driving force behind rising drug spending.

U.S. Carbon Emissions Are Actually Dropping


Increased natural gas consumption helped bring down U.S. greenhouse gas emissions in 2019, according to a recent report from the U.S. Energy Information Administration.

"Buy American" Executive Order Could Slow Delivery of a Coronavirus Cure


President Trump is considering a "Buy American" executive order requiring government agencies to purchase medicines and medical supplies domestically.

Don't Disrupt the Supply Chain in the Midst of a Pandemic


The Trump administration fears America has lost its ability to mass-produce the medicines and medical supplies needed to fight the coronavirus and other, future pandemics. So it's considering an executive order to bring drug and medical-supply manufacturing back to the United States.

Intellectual Property Makes Sure Drug Makers Deliver


House Democrats Peter DeFazio, Rosa DeLauro, Lloyd Doggett, and Jan Schakowsky want to nullify intellectual property rights on any experimental treatments for COVID-19. They believe their proposals will prevent "price gouging and profiteering" without harming innovation.

Move These Projects Forward and Get America Back to Work


With more than 40 million Americans out of a job due to the coronavirus pandemic, states are scrambling to help the unemployed and laying plans to reopen the economy.

COVID-19 Cost-Effectiveness Research Deepens Racial Disparities


A newly released study by the Institute for Clinical and Economic Review (ICER), a Boston-based nonprofit, attempts to answer a weighty question: How much should it cost to treat the coronavirus?